Santen Pharmaceutical Co. Ltd. logo

Santen Pharmaceutical Co. Ltd.

SNPHY | OTC
Chart Builder DCF Calculator
$11.23
+$0.45 (+4.17%)
At close: Oct 30, 2026, 3:15 PM ET
$11.23
$0.00 (0.00%)
After-hours: Oct 30, 2026, 4:00 PM ET
Fiscal Quarter
Period Ending
Q1 2027
Jun 30, 2026
Q4 2026
Mar 31, 2026
Q3 2026
Dec 31, 2025
Q2 2026
Sep 30, 2025
Q1 2026
Jun 30, 2025
Q4 2025
Mar 31, 2025
Q3 2025
Dec 31, 2024
Q2 2025
Sep 30, 2024
Q1 2025
Jun 30, 2024
Q4 2024
Mar 31, 2024
Q3 2024
Dec 31, 2023
Q2 2024
Sep 30, 2023
Q1 2024
Jun 30, 2023
Q4 2023
Mar 31, 2023
Q3 2023
Dec 31, 2022
Q2 2023
Sep 30, 2022
Q1 2023
Jun 30, 2022
Q4 2022
Mar 31, 2022
Q3 2022
Dec 31, 2021
Q2 2022
Sep 30, 2021
Q1 2022
Jun 30, 2021
Revenue
68.96B 80.86B 72.88B 69.14B 68.74B 77.23B 76.37B 71.63B 74.77B 79.13B 77.03B 73.42B 72.39B 79.25B 70.87B 63.38B 65.53B 70.46B 67.04B 63.77B 64.99B
Cost of Revenue
31.27B 31.19B 34.34B 31.33B 33.8B 33.51B 36.27B 33.57B 34.44B 34.04B 34.53B 31.8B 32.35B 29.79B 31.61B 30.11B 30.96B 29.45B 32.31B 28.31B 28.96B
Gross Profit
37.69B 49.67B 38.54B 37.81B 34.94B 43.72B 40.1B 38.06B 40.33B 45.09B 42.5B 41.62B 40.04B 49.46B 39.26B 33.27B 34.57B 41.01B 34.74B 35.46B 36.02B
Operating Income
8.06B 17.07B 10.28B 10.34B 7.53B 13.13B 11.78B 11.78B 13.45B 11.1B 15.18B 13.35B 12.67B 12.09B 8.64B 3.24B 8.05B 9.26B 7.6B 10.04B 9.45B
Interest Income
957M 300M 455M 257M 627M 2.57B 421M 306M 702M 259M 486M 152M 1.05B 159M 428M 128M 1.39B 1.33B 540M 82M 590M
Pretax Income
8.34B 19.37B 10.44B 10.18B 7.45B 12.17B 11.47B 10.39B 13.45B -3.69B 9.48B 11.21B 12.87B 5.79B 7.51B -28.18B 9.07B 9.94B 7.28B 9.22B 9.55B
Net Income
7.19B 15.55B 7.88B 8.06B 5.88B 8.79B 8.69B 8.14B 10.63B 30M 7.33B 8.87B 10.41B 1.12B 5.98B -28.7B 6.66B 7.87B 5.04B 6.97B 7.38B
Selling & General & Admin
23.38B 24.79B 22.27B 21.31B 21.2B 23.27B 22.49B 20.84B 21.38B 26.78B 21.58B 22.11B 21.07B 30.76B 23.21B 22.87B 19.43B 24.18B 20.67B 19.21B 20.45B
Research & Development
6.25B 7.81B 6B 6.16B 6.21B 7.33B 5.83B 5.44B 5.5B 7.21B 5.75B 6.16B 6.3B 6.62B 7.42B 7.17B 7.1B 7.57B 6.46B 6.22B 6.12B
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
29.63B 32.6B 28.27B 27.48B 27.41B 30.6B 28.32B 26.28B 26.88B 33.99B 27.32B 28.27B 27.37B 37.37B 30.62B 30.04B 26.53B 31.75B 27.14B 25.42B 26.57B
Interest Expense
738M 512M 318M 415M 749M 1.4B 273M 636M 407M 1.68B 703M 486M 168M 790M 1.13B 408M 123M 475M 293M 163M 277M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
60.9B 63.79B 62.61B 58.81B 61.21B 64.1B 64.59B 59.85B 61.32B 68.03B 61.85B 60.07B 59.72B 67.16B 62.23B 60.14B 57.49B 61.2B 59.44B 53.73B 55.53B
Income Tax Expense
1.14B 3.8B 2.3B 2.19B 1.59B 3.67B 2.83B 2.29B 2.84B -3.81B 2.18B 2.34B 2.46B 4.69B 1.58B 538M 2.38B 2.05B 2.24B 2.29B 2.19B
Shares Outstanding (Basic)
321.34M 325.02M 322.72M 329.97M 339.17M 341.36M 343.09M 349.49M 359.15M 363.21M 353.63M 360.45M 372.78M 377.03M 385.52M 379.87M 396.75M 400.27M 399.77M 399.73M 399.63M
Shares Outstanding (Diluted)
322.6M 325.72M 323.64M 330.15M 340.16M 341.72M 344.41M 350.22M 360.44M 363.21M 354.92M 361.6M 373.98M 377.03M 386.55M 379.87M 397.31M 400.55M 400.54M 400.48M 400.42M
EPS (Basic)
22.39 47.85 24.42 24.43 17.33 25.73 25.34 23.29 29.61 0.08 20.73 24.60 27.93 2.96 15.49 -75.56 16.78 19.66 12.60 17.42 18.47
EPS (Diluted)
22.30 47.75 24.35 24.42 17.28 25.70 25.24 23.24 29.50 0.08 20.66 24.52 27.85 2.96 15.46 -75.56 16.77 19.65 12.59 17.39 18.44
EBITDA
12.78B 24.43B 15.38B 15.29B 12.7B 17.97B 16.25B 15.36B 18.56B 2.56B 14.87B 16.6B 17.07B 10.69B 12.76B -23.22B 13.67B 14.93B 11.81B 13.87B 13.64B
EBIT
8.06B 19.88B 10.76B 10.6B 8.2B 13.57B 11.74B 11.03B 13.86B -2B 10.19B 11.69B 13.04B 6.58B 8.63B -27.77B 9.2B 10.42B 7.57B 9.39B 9.83B
Depreciation & Amortization
4.72B 4.55B 4.62B 4.69B 4.5B 4.4B 4.51B 4.34B 4.71B 4.56B 4.69B 4.9B 4.03B 4.1B 4.13B 4.55B 4.47B 4.51B 4.24B 4.49B 3.81B

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.